Bambusa Therapeutics Funding: $105M Raised, Series A (2025)
Bambusa Therapeutics is a Biotech company based in Boston. It has raised $105M in total funding. Latest round: Series A.
Bambusa Therapeutics funding overview
Bambusa Therapeutics is a Biotech company based in Boston. Bambusa Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2025. The round record for Bambusa Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Janus Henderson Investors, Redmile Group, Invus, ADAR1 Capital Management, BVF Partners L.P. and 3 others. 9 distinct backers are named across the disclosed rounds.
Bambusa Therapeutics at a glance
Total raised
$105M
Latest round
Series A
Latest round date
February 2025
Industry
Biotech
Headquarters
Boston
Notable investors
RA Capital Management, Janus Henderson Investors, Redmile Group, Invus, ADAR1 Capital Management, BVF Partners L.P., Dawn Biopharma, Salvia GmbH
Frequently asked about Bambusa Therapeutics funding
How much has Bambusa Therapeutics raised?
Bambusa Therapeutics has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Bambusa Therapeutics?
RA Capital Management, Janus Henderson Investors, Redmile Group, Invus, ADAR1 Capital Management, BVF Partners L.P. are named among the investors backing Bambusa Therapeutics.
What was the latest Bambusa Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2025.
Where is Bambusa Therapeutics based?
Bambusa Therapeutics is based in Boston.
What sector does Bambusa Therapeutics operate in?
Bambusa Therapeutics is tracked under Biotech from Boston, with $105M in disclosed funding.
When did Bambusa Therapeutics last raise?
The last disclosed Bambusa Therapeutics round closed in February 2025 at Series A.
Totals shown for Bambusa Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
